- Home
- EYEN vs SRBK Comparison
EYEN vs SRBK Comparison
Compare EYEN & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- SRBK
- Stock Information
- Founded
- EYEN 2014
- SRBK 1887
- Country
- EYEN United States
- SRBK United States
- Employees
- EYEN N/A
- SRBK N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- SRBK
- Sector
- EYEN Health Care
- SRBK
- Exchange
- EYEN Nasdaq
- SRBK Nasdaq
- Market Cap
- EYEN 2.9M
- SRBK 117.4M
- IPO Year
- EYEN 2018
- SRBK N/A
- Fundamental
- Price
- EYEN $15.82
- SRBK $13.49
- Analyst Decision
- EYEN Hold
- SRBK
- Analyst Count
- EYEN 4
- SRBK 0
- Target Price
- EYEN $2.00
- SRBK N/A
- AVG Volume (30 Days)
- EYEN 9.3M
- SRBK 123.4K
- Earning Date
- EYEN 08-11-2025
- SRBK 07-25-2025
- Dividend Yield
- EYEN N/A
- SRBK 0.74%
- EPS Growth
- EYEN N/A
- SRBK N/A
- EPS
- EYEN N/A
- SRBK N/A
- Revenue
- EYEN $67,063.00
- SRBK $27,988,000.00
- Revenue This Year
- EYEN $7,680.45
- SRBK N/A
- Revenue Next Year
- EYEN $315.38
- SRBK N/A
- P/E Ratio
- EYEN N/A
- SRBK N/A
- Revenue Growth
- EYEN 663.82
- SRBK 23.80
- 52 Week Low
- EYEN $0.85
- SRBK $9.12
- 52 Week High
- EYEN $124.80
- SRBK $13.65
- Technical
- Relative Strength Index (RSI)
- EYEN 77.71
- SRBK 61.79
- Support Level
- EYEN $7.50
- SRBK $13.40
- Resistance Level
- EYEN $14.33
- SRBK $13.29
- Average True Range (ATR)
- EYEN 2.92
- SRBK 0.17
- MACD
- EYEN 0.87
- SRBK 0.04
- Stochastic Oscillator
- EYEN 90.98
- SRBK 93.15
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.